Publication | Open Access

Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme

Transdermal OestradiolUrologyMedicineGynecologyProstatic DiseaseEndocrinologyOncologyAndrogen SuppressionEndocrine-related Cancer